More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.

Evidence is mounting that GLP-1 drugs may play a role in reducing cancer risk and deaths from certain cancers.

By Gnaneshwar Rajan and Sriparna Roy Jan 30 (Reuters) - Regeneron Pharmaceuticals' executives voiced confidence in its ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

Retatrutide is an exciting GLP-1 drug that has explosive potential.

The world of weight loss drugs can be confusing. There are so many types and brand names, and then there’s the big question: Does weight loss medication work? The short answer is yes. Weight loss ...

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain.

Last month, the survey firm Statista published Americans’ most common 2026 resolutions. Three of the top five involved losing weight, eating healthy and exercising more. But studies also show a ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re pregnant or hoping to become pregnant, it’s ...

Did you know that weight-loss drugs might have the potential to heal the habit of substance abuse?In a recent study published ...